UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 31

Sortiert nach

Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression?

Cancer Immunology, Immunotherapy, 2014-01, Vol.63 (1), p.67-72

Whiteside, Theresa L.

2014

Link zum Volltext

Verfügbarkeit prüfen

Disarming suppressor cells to improve immunotherapy

Cancer Immunology, Immunotherapy, 2012-02, Vol.61 (2), p.283-288

Whiteside, Theresa L.

2012

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic reduction of cell-mediated immunosuppression in mycosis fungoides and Sézary syndrome

Cancer Immunology, Immunotherapy, 2018-03, Vol.67 (3), p.423-434

2018

Link zum Volltext

Verfügbarkeit prüfen

Down-regulation of ζ-chain expression in T cells: a biomarker of prognosis in cancer?

Cancer Immunology, Immunotherapy, 2004-10, Vol.53 (10), p.865-878

WHITESIDE, Theresa L

2004

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors

Cancer Immunology, Immunotherapy, 2010-01, Vol.59 (1), p.73-79

2010

Link zum Volltext

Verfügbarkeit prüfen

A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients

Cancer Immunology, Immunotherapy, 2012-03, Vol.61 (3), p.373-384

2012

Link zum Volltext

Verfügbarkeit prüfen

Impact of combination immunochemotherapies on progression of 4NQO-induced murine oral squamous cell carcinoma

Cancer Immunology, Immunotherapy, 2019-07, Vol.68 (7), p.1133-1141

2019

Link zum Volltext

Verfügbarkeit prüfen

Expansion and characteristics of human T regulatory type 1 cells in co-cultures simulating tumor microenvironment

Cancer Immunology, Immunotherapy, 2007-09, Vol.56 (9), p.1429-1442

2007

Link zum Volltext

Verfügbarkeit prüfen

Dendritic cell biology and cancer therapy

Cancer Immunology, Immunotherapy, 2004-03, Vol.53 (3), p.240-248

2004

Link zum Volltext

Verfügbarkeit prüfen

Rapid turnover of the CD8+CD28- T-cell subset of effector cells in the circulation of patients with head and neck cancer

Cancer Immunology, Immunotherapy, 2003-10, Vol.52 (10), p.599-607

2003

Link zum Volltext

Verfügbarkeit prüfen

Increased lymphocyte infiltration in patients with head and neck cancer treated with the IRX-2 immunotherapy regimen

Cancer Immunology, Immunotherapy, 2012-06, Vol.61 (6), p.771-782

2012

Link zum Volltext

Verfügbarkeit prüfen

Immune responses to p53 in patients with cancer:Enrichment in tetramer+ p53 peptide-specific T cells and regulatory T cells at tumor sites

Cancer Immunology, Immunotherapy, 2005-11, Vol.54 (11), p.1072-1081

2005

Link zum Volltext

Verfügbarkeit prüfen

Maturation of circulating dendritic cells and imbalance of T-cell subsets in patients with squamous cell carcinoma of the head and neck

Cancer Immunology, Immunotherapy, 2006-02, Vol.55 (2), p.151-159

2006

Link zum Volltext

Verfügbarkeit prüfen

Regulation of antigen presentation machinery in human dendritic cells by recombinant adenovirus

Cancer Immunology, Immunotherapy, 2009-01, Vol.58 (1), p.121-133

2009

Link zum Volltext

Verfügbarkeit prüfen

A short course of neoadjuvant IRX-2 induces changes in peripheral blood lymphocyte subsets of patients with head and neck squamous cell carcinoma

Cancer Immunology, Immunotherapy, 2012-06, Vol.61 (6), p.783-788

2012

Link zum Volltext

Verfügbarkeit prüfen

tyranny of statistics in medicine: a critique of unthinking adherence to an arbitrary p value

Cancer Immunology, Immunotherapy, 2010-08, Vol.59 (8), p.1137-1140

2010

Link zum Volltext

Verfügbarkeit prüfen

CD4+ T cell responses to HLA-DP5-restricted wild-type sequence p53 peptides in patients with head and neck cancer

Cancer Immunology, Immunotherapy, 2009-09, Vol.58 (9), p.1441-1448

2009

Link zum Volltext

Verfügbarkeit prüfen

Immune restoration in head and neck cancer patients after in vivo COX-2 inhibition

Cancer Immunology, Immunotherapy, 2007-10, Vol.56 (10), p.1645-1652

2007

Link zum Volltext

Verfügbarkeit prüfen

Targeting the immune system: novel therapeutic approaches in squamous cell carcinoma of the head and neck

Cancer Immunology, Immunotherapy, 2004-12, Vol.53 (12), p.1055-1067

2004

Link zum Volltext

Verfügbarkeit prüfen

Signaling defects in T lymphocytes of patients with malignancy

Cancer Immunology, Immunotherapy, 1999-10, Vol.48 (7), p.346-352

WHITESIDE, T. L

1999

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer

Cancer Immunology, Immunotherapy, 2005-03, Vol.54 (3), p.254-264

2005

Link zum Volltext

Verfügbarkeit prüfen

Cellular and molecular pathways in the tumor immunoenvironment: 3rd Cancer Immunotherapy and Immunomonitoring (CITIM) meeting, 22–25 April 2013, Krakow, Poland

Cancer Immunology, Immunotherapy, 2014-01, Vol.63 (1), p.73-80

2014

Link zum Volltext

Verfügbarkeit prüfen

The role of Fas/FasL in immunosuppression induced by human tumors

Cancer Immunology, Immunotherapy, 1998-06, Vol.46 (4), p.175-184

1998

Link zum Volltext

Verfügbarkeit prüfen

Effects of cytokines on in vitro growth of tumor-infiltrating lymphocytes obtained from human primary and metastatic liver tumors

Cancer Immunology Immunotherapy, 1991-09, Vol.32 (5), p.280-288

1991

Link zum Volltext

Verfügbarkeit prüfen

Tumor-infiltrating lymphocytes : their phenotype, functions and clinical use

Cancer Immunology Immunotherapy, 1994-01, Vol.39 (1), p.15-21

1994

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 31

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCancer Immunology, Immunotherapy : Cii

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(31)

Sprache

Englisch
(31)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Humans
(30)
Immunology
(29)
Oncology
(29)
Life Sciences & Biomedicine
(28)
Science & Technology
(28)
Biological And Medical Sciences
(22)
Medical Sciences
(21)
Antineoplastic Agents
(17)
Immunotherapy
(17)
Pharmacology. Drug Treatments
(17)
Tumors
(16)
Cancer Research
(14)
Cancer
(12)
Medicine
(12)
Medicine & Public Health
(12)
Original
(12)
Female
(11)
Lymphocytes
(11)
Aged
(9)
Head And Neck Neoplasms - Immunology
(9)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(31)
MEDLINE
(31)
SpringerLink (Online service)
(31)

Zeitschrift / Serie

Menü

Weitere Dienste

Einstellungen

Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression?

Disarming suppressor cells to improve immunotherapy

Therapeutic reduction of cell-mediated immunosuppression in mycosis fungoides and Sézary syndrome

Down-regulation of ζ-chain expression in T cells: a biomarker of prognosis in cancer?

Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors

A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients

Impact of combination immunochemotherapies on progression of 4NQO-induced murine oral squamous cell carcinoma

Expansion and characteristics of human T regulatory type 1 cells in co-cultures simulating tumor microenvironment

Dendritic cell biology and cancer therapy

Rapid turnover of the CD8+CD28- T-cell subset of effector cells in the circulation of patients with head and neck cancer

Increased lymphocyte infiltration in patients with head and neck cancer treated with the IRX-2 immunotherapy regimen

Immune responses to p53 in patients with cancer:Enrichment in tetramer+ p53 peptide-specific T cells and regulatory T cells at tumor sites

Maturation of circulating dendritic cells and imbalance of T-cell subsets in patients with squamous cell carcinoma of the head and neck

Regulation of antigen presentation machinery in human dendritic cells by recombinant adenovirus

A short course of neoadjuvant IRX-2 induces changes in peripheral blood lymphocyte subsets of patients with head and neck squamous cell carcinoma

tyranny of statistics in medicine: a critique of unthinking adherence to an arbitrary p value

CD4+ T cell responses to HLA-DP5-restricted wild-type sequence p53 peptides in patients with head and neck cancer

Immune restoration in head and neck cancer patients after in vivo COX-2 inhibition

Targeting the immune system: novel therapeutic approaches in squamous cell carcinoma of the head and neck

Signaling defects in T lymphocytes of patients with malignancy

Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer

Cellular and molecular pathways in the tumor immunoenvironment: 3rd Cancer Immunotherapy and Immunomonitoring (CITIM) meeting, 22–25 April 2013, Krakow, Poland

The role of Fas/FasL in immunosuppression induced by human tumors

Effects of cytokines on in vitro growth of tumor-infiltrating lymphocytes obtained from human primary and metastatic liver tumors

Tumor-infiltrating lymphocytes : their phenotype, functions and clinical use

Aktive Filter

Suchergebnisse filtern